BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Pipobroman

An antineoplastic agent that acts by alkylation.

76+ PubMed studies analyzed · 8 RCTs · Evidence Score: 50.1

Research Domains

Pipobroman has been studied across 9 research domains including 🔬 Oncology, 🛡️ Immunity, 😴 Sleep, ✨ Skin & Hair, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 20% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Pipobroman, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

dibromoacetic
2 shared targets
acrolein
2 shared targets
Guanazole
2 shared targets
Aminopyrine
2 shared targets
Phenylglyoxal
2 shared targets
Dapsone
2 shared targets
Carmustine
2 shared targets
Sulfaphenazole
2 shared targets
methoprene
2 shared targets
Sulfinpyrazone
3 shared targets
Loading evidence profile...

This evidence profile for Pipobroman is generated deterministically from 76 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.